ClinicalTrials.gg
Drug

Zoledronic Acid clinical trials

Also written Zometa, Zoledronate, Aclasta and ZOL446.

studies test it
275
open now
16
in phase 3
95
first study started
1998

How each study uses Zoledronic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Zoledronic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Aug 2001 · ZOMETA · NDA 021223 (FDA, Drugs@FDA)
European Union
20 Mar 2001 · Zometa · EMEA/H/C/000336 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Zoledronic acid
212
NDC-zoledronate
6
Reclast, Aclasta
6
Zoledronic Acid 5Mg/Bag 100Ml Inj
4
Zoledronic acid 4 mg
4

Brand

Zometa
83
Aclasta
20
Reclast
18

Development codes

ZOL446
15
CGP 42446
6
CGP42446A
6
AK156
1
CZOL446E
1
MER-101
1

Other names

Zoledronate
37

Studies by the year they started

275 studies that test it; most in 2005 (29)

Studies that test Zoledronic Acid, by start year
YearStudies
19981
19992
20003
20015
200216
200321
200426
200529
200625
200711
200817
200918
20109
20118
201211
20135
20142
20158
20167
20177
20186
20196
20204
20218
20223
20236
20244
20253
20264

By phase

A phase 1/2 study counts in both.

Phase 1
23
Phase 2
83
Phase 3
95
Phase 4
71
No phase
22

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 86 · Other 189

Novartis Pharmaceuticals (57) · Novartis (18) · Massachusetts General Hospital (5) · M.D. Anderson Cancer Center (4) · Alliance for Clinical Trials in Oncology (4) · University of Wisconsin, Madison (4) · University of Nebraska (3) · Ottawa Hospital Research Institute (3)

Often tested with

Tested in the same studies.

Denosumab (11) · Letrozole (8) · Docetaxel (6) · Alendronate (4) · Teriparatide (3) · Cyclophosphamide (3) · Romosozumab (3) · Pamidronate (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 2 in phase 3

Studies that test Zoledronic Acid, phase 3 first.

Studies

Open first, then newest update. How each study uses Zoledronic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 275

See all 275 studies that test Zoledronic Acid →

Given beside what is tested · 19 — Zoledronic Acid is usual care or a partner of the new treatment
As the comparator · 22 — what is tested is compared with Zoledronic Acid

Showing 20 of 22.

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Zoledronic Acid · ClinicalTrials.gg INT006666

  • MeSH (NLM) D000077211Zoledronic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6XC1PAD3KFZOLEDRONIC ACIDConfirmed FDA, NLM, Wikidata
  • RxNorm 77655Confirmed FDA, Wikidata
  • Wikidata Q28852343zoledronic acid monohydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1699Zoledronic AcidConfirmed FDA, Wikidata

Also registered as zoledronic acid anhydrous (UNII 70HZ18PH24 · RxNorm 1546014).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.